Strikingly, when analyzing the immunophenotype of tumor cells within this cluster, an upward trend in the expression levels of CD19, CD34, CD24, CD20, nuTdT, cyMPO, and CD33 was recorded (Figure 5B). The gene discussed is CD19; the disease is neoplasm.